Patents for C07K 19 - Hybrid peptides (29,428) |
---|
03/26/1991 | CA1282020C Proteins for the production of bioadhesives |
03/24/1991 | CA2025942A1 Antibodies against highly conserved amino acid sequences of immunogenic substances, a process for the preparation of these antibodies and the use thereof in immunoassays |
03/21/1991 | WO1991003552A1 Recombinant negative strand rna virus expression systems and vaccines |
03/21/1991 | WO1991003255A1 Polypeptide vaccines against foot-and-mouth disease virus |
03/20/1991 | EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus |
03/20/1991 | EP0417196A1 Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto |
03/20/1991 | EP0172865B1 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
03/20/1991 | CA2025481A1 Vaccine for aids and hepatitis b |
03/19/1991 | US5001056 Linking proliferating cells and B-cells through antigens and surface immunoglobulins, fusing |
03/15/1991 | WO1991004050A1 Therapeutic compositions; methods for treatment of hiv infections |
03/15/1991 | CA2065029A1 Therapeutic compositions; methods for treatment of hiv infections |
03/13/1991 | EP0416673A1 Method for the expression of heterologous proteins produced in fused form in E. coli, use thereof, expression vectors and recombinant strains |
03/09/1991 | CA2024918A1 Fused proteins and production thereof |
03/07/1991 | WO1991002978A1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids |
03/07/1991 | WO1991002807A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
03/07/1991 | WO1991002792A1 Alkaline proteolytic enzyme and method of production |
03/07/1991 | WO1991002754A1 Fusion proteins comprising gm-csf and il-3 |
03/05/1991 | US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy |
03/05/1991 | US4997758 Immobilized enzymes |
02/27/1991 | EP0414178A2 Non-human primate CD4 polypeptides and human CD4 molecules capable of being glycosylated |
02/26/1991 | US4996142 Non-radioactive nucleic acid hybridization probes |
02/26/1991 | CA2023969A1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
02/24/1991 | WO1991002743A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/24/1991 | CA2065010A1 Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof |
02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
02/21/1991 | WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
02/21/1991 | WO1991001745A1 Growth factors containing vitamin a or other retinoids and uses thereof |
02/21/1991 | WO1991001743A1 Stabilized protein or peptide conjugates |
02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
02/20/1991 | EP0413622A1 Albumin derivatives with therapeutic functions |
02/19/1991 | CA1280363C Peptide composition and method for the detection of antibodies to htlv-iii |
02/13/1991 | EP0412766A1 Peptide fragments of HIV |
02/13/1991 | EP0412465A1 Process for correct biocatalytic chain folding of denaturated recombinant fusion proteins |
02/13/1991 | EP0412115A1 Hybrid peptides and methods of their use |
02/10/1991 | WO1991001996A1 Peptide fragments of hiv |
02/10/1991 | CA2064691A1 Peptide fragments of hiv |
02/07/1991 | WO1991001335A1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
02/07/1991 | DE3925183A1 Proteine mit tnf-wirkung Proteins with tnf-effective |
02/06/1991 | EP0412050A1 Novel cytokines |
02/06/1991 | EP0411096A1 Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition |
02/03/1991 | WO1991002000A1 Il-2 deletion mutants |
02/03/1991 | CA2064696A1 Il-2 deletion mutants |
01/30/1991 | WO1991001998A1 Proteins with tnf activity |
01/30/1991 | EP0410280A1 Heterobifunctional compounds |
01/30/1991 | EP0177531B1 Antibodies, manufacture and use |
01/30/1991 | CA2051124A1 Proteins with tnf activity |
01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
01/23/1991 | EP0408661A1 Methods of generating desired amino-terminal residues in proteins |
01/23/1991 | EP0408585A1 Immobilized artificial membranes |
01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
01/16/1991 | EP0407451A1 General cancer-associated scm-recognition factor, preparation and method of use |
01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
01/15/1991 | WO1991001146A1 Cytokine and hormone carriers for conjugate vaccines |
01/15/1991 | CA2063271A1 Cytokine and hormone carriers for conjugate vaccines |
01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
01/10/1991 | WO1991000294A1 Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates |
01/10/1991 | WO1991000111A1 Targetting agents |
01/10/1991 | WO1991000100A2 Toxin uses |
01/10/1991 | WO1990012807A3 Purified, highly specific antibodies against gene products including retinoblastoma and method |
01/09/1991 | EP0407259A1 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, preparation and method and application therefor |
01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
01/09/1991 | EP0406357A1 Functional recombinantly prepared synthetic protein polymer |
01/09/1991 | EP0406286A1 Dna encoding a ryegrass pollen allergen |
01/07/1991 | WO1991001004A1 Hybrid molecules |
01/07/1991 | CA2035868A1 Hybrid molecules |
01/06/1991 | CA2020303A1 Cytokines |
01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
01/02/1991 | EP0405763A1 GRF peptides |
01/01/1991 | US4981953 Antitumor |
01/01/1991 | US4981784 Retinoic acid receptor method |
01/01/1991 | US4981782 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
12/31/1990 | WO1991000350A1 Nonglycosylated human interleukin-3 analog proteins |
12/31/1990 | WO1991000296A1 Enzymatically binding bioactive materials to proteins |
12/31/1990 | CA2063434A1 Enzymatically binding bioactive materials to proteins |
12/31/1990 | CA2033182A1 Nonglycosylated human interleukin-3 analog proteins |
12/27/1990 | WO1990015815A1 Gamma retinoic acid receptor |
12/27/1990 | WO1990015798A1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
12/27/1990 | WO1990015627A1 Methods and compositions for the preparation and use of site-directed immunologic reagents |
12/27/1990 | WO1990015614A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
12/27/1990 | WO1990013314A3 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
12/27/1990 | EP0404546A2 Heteropolymeric protein production |
12/27/1990 | EP0404097A2 Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof |
12/27/1990 | EP0404003A2 Chimeric mouse-human KM10 antibody with specificity to a human tumor cell antigen |
12/27/1990 | EP0214995B1 Immunotoxin and method of making |
12/27/1990 | EP0120958B1 Characterization of oncogenes and assays based thereon |
12/27/1990 | CA2066692A1 Gamma retinoic acid receptor |
12/26/1990 | CA2019665A1 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, processes for preparing them and their applications |
12/20/1990 | DE3919915A1 Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen Aminoalkylmaleimide and derived hapten and antigen derivatives and conjugates with peptides or proteins |
12/19/1990 | EP0403312A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
12/19/1990 | EP0403156A1 Improved monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use |
12/19/1990 | CA2019323A1 Chimeric mouse-human km10 antibody with specificity to a human tumor cell antigen |
12/18/1990 | CA1277932C Human calcitonin precursor polyprotein structural gene |
12/17/1990 | WO1990015860A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
12/16/1990 | WO1990015878A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
12/13/1990 | WO1990015074A1 Methods for enhancing the rate of modification of metastable bonds |
12/12/1990 | EP0402300A2 Production of bacteria and yeast of hemoglobin and analogues thereof |